ClinicalTrials.gg
Not yet recruitingNCT06720649BALLCAUpdated Dec 6, 2024

Benefits of Ballistic Tests After the Anterior Cruciate Ligament Surgery

An interventional study of isokinetic test and Ballistic test in Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Rupture, sponsored by Almaviva Sante. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by Almaviva Sante · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

During physical activities, the time available to produce a force is infinitely shorter than the time required to reach maximal muscle capacity.

Previous studies have observed that the time elapsed between ground contact and ACL rupture is on average 50-60 ms, suggesting that this is the time window available for any attempt at dynamic stabilization of the joint through muscle contraction.

Sports movements include ballistic movements, defined as very fast movements whose objective is to accelerate a moving mass as much as possible so that it reaches a high speed in a very short time. This is the case for vertical jumps, running and most movements performed in physical and sporting activities.

Thus; (1) isokinetic tests do not allow a rigorous analysis of the components related to the speed of the movement; (2) functional tests such as jumping, which only give a distance between one leg and the other, do not allow the calculation of precise and reproducible variables concerning the force and speed of the movement, in particular during the first milliseconds of the movement, and do not provide information on compensation phenomena. It is therefore interesting to use the ballistic tests developed to monitor the movements of athletes as a new possible indicator of the return to sport.

The main objective of this study is to evaluate the performance of ballistic tests in predicting failure to return to physical activity 24 months after ACL surgery.

02

Conditions studied

  • Anterior Cruciate Ligament Injuries
  • Anterior Cruciate Ligament Rupture
03

In context

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

This study's planned enrollment of 140 is above the median of 56 across 458 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Almaviva Sante is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (> 18 years),
  • Patient who has undergone ACL reconstruction of the hamstrings with or without associated extra-articular plastic surgery:

    • Isolated ACL sprain without injury to the collateral ligaments or the PCL,
    • ACL reconstruction without associated meniscal injury or with repaired or menisctomized meniscal injury,
  • Having to perform a K-STARTS test and an isokinetic test,
  • Having the Tegner score before the rupture.

Exclusion criteria

Exclusion Criteria:

  • Patient with high cardio-respiratory risk,
  • Osteoarticular and neuromuscular traumatic sequelae of the lower limbs,
  • Degenerative neuromuscular diseases,
  • Connective Tissue and Collagen Disease (e.g. Marfan),
  • Follow-up of a medical treatment that may influence the neuro-muscular system (e.g., antidepressants, etc.) during the tests,
  • Pregnant, parturient or breastfeeding patient.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    patient underwent ACL reconstruction

    Other: isokinetic test · Other: Ballistic test · Other: K-STARTS test · Other: Questionnaires

Interventions

  • Otherisokinetic test

    Bilateral strength will be measured using a Contrex ® dynamometer equipped with an exercise table. Each subject will perform isokinetic tests of the right and left knee extensors and flexors. Subjects will be stabilized by straps during testing and the joint rotation axis will be aligned with the input shaft of the dynamometer.

  • OtherBallistic test

    ballistic squat jumps performed in the supine position on a frictionless sled at a resistance between 0% of body weight (BW)

  • OtherK-STARTS test

    The K-STARTS (Knee Health Athletic Return To Sport) test brings together a set of 7 tests validated in the scientific literature to assess the control and neuromuscular capacities of the lower limb when performing dynamic movements as well as apprehension when resuming activity. Test in 30 minutes with physical exercises and questionnaire.

  • OtherQuestionnaires

    KOOS (Knee Injury and Osteoarthritis Outcome Score) Questionnaire

06

What researchers measure

Primary outcomes

  1. Analysis of the kinetics of force waves produced at high speed during ballistic movement

    Analysis of the kinetics of force waves produced at high speed during a ballistic movement will make it possible to determine the ability to resume physical activity at a level similar to that before the rupture in the absence of injury (risk = 2.3 / no risk = 0.1). Failure to resume physical activity 24 months after ACL surgery is defined by the occurrence of one of the following events: * Graft rupture, * Contralateral ACL rupture, * Decrease of at least 2 points in the Tegner 24 months after cruciate ligament surgery compared to the Tegner before the rupture

    Time frame: 24 Months

Secondary outcomes

  1. Return to physical activity via isokinetic test

    Fitness to resume physical activity via isokinetic test will be determined by quadriceps torque values (\>3.0 Nm/kg) and an LSI\>90%.

    Time frame: 24 Months

  2. Return to physical activity via the K-STARTS test

    Fitness to resume physical activity via the K-STARTS test will be determined by a total score ≥ 18 points and individual results of the tests comprising the K-START between 2 and 3.

    Time frame: 24 Months

07

Study locations

1 site
  • Clinique Chantecler
    Marseille, 13012, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2024; primary completion for Dec 2026, 24 months later.

Of 277 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 24 months is below that.

Counting every sponsor, half of 286 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2024
First posted
Dec 6, 2024
StartEst.
Dec 15, 2024
Primary completionEst.
Dec 15, 2026
CompletionEst.
Jun 15, 2028
Last update
Dec 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06720649
Lead sponsor
Almaviva Sante
Responsible party
Sponsor
First posted
Dec 6, 2024
Start date
Dec 15, 2024 (estimated)
Primary completion
Dec 15, 2026 (estimated)
Completion
Jun 15, 2028 (estimated)
Last update
Dec 6, 2024

Study contacts

Dr Nicolas MORIN-SALVO, MD
Contact
n.morin-salvo@live.fr
+33 4.91.61.17.95
Arnaud HAYS, PhD
Contact
arnaud.hays@univ-amu.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion